Cataract Extraction Without Prophylactic Treatment in Patients With Severe Factor XI Deficiency

American Journal of Ophthalmology

Volumn 148, Issue 6, 2009, Pages

  Fabian, Ido Didi ^a   Sachs, Dan ^a   Moisseiev, Joseph ^a   Alhalel, Amir ^a   Grinbaum, Aharon ^a   Seligsohn, Uri ^b   Salomon, Ophira ^b  

^a TEL AVIV UNIVERSITY   (Israel)

^b The Amalia Biron Research Institute of Thrombosis and Hemostasis   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 11;

ADULT; AGED; ARTICLE; BLOOD CLOTTING FACTOR 11 DEFICIENCY; CATARACT; CATARACT EXTRACTION; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; CLOSED ANGLE GLAUCOMA; CORNEA; DISEASE SEVERITY; FEMALE; FOLLOW UP; GENE MUTATION; HUMAN; INTRAOCULAR HEMORRHAGE; INTRAOPERATIVE PERIOD; LENS IMPLANT; MALE; OPEN ANGLE GLAUCOMA; OUTCOME ASSESSMENT; PHACOEMULSIFICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETINA MACULA AGE RELATED DEGENERATION; TREATMENT OUTCOME;

EID: 70449688123     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2009.07.013     Document Type: Article

References (20)

1. Bolton-Maggs P.H. The management of factor XI deficiency. Haemophilia 4 (1998) 683-688
2. Kato A., Asakai R., Davie E., and Aoki N. Factor XI gene (F11) is located on the distal end of the long-arm of human chromosome 4. Cytogenet Cell Genet 52 (1989) 77-78
3. Asakai R., Chung D.W., Davie E.W., and Seligsohn U. Factor XI deficiency in Ashkenazi Jews in Israel. N Engl J Med 325 (1991) 153-158
4. Salomon O., Zivelin A., Livnat T., et al. Prevalence, causes, and characterization of factor XI inhibitors in patients with inherited factor XI deficiency. Blood 101 (2003) 4783-4788
5. Quelin F., Trossaert M., Sigaud M., Mazancourt P.D., and Fressinaud E. Molecular basis of severe factor XI deficiency in seven families from the west of France. Seven novel mutations, including an ancient Q88X mutation. J Thromb Haemost 2 (2004) 71-76
6. Zucker M., Zivelin A., Teitel J., and Seligsohn U. Induction of an inhibitor antibody to factor XI in a patient with severe inherited factor XI deficiency by Rh immune globulin. Blood 111 (2008) 1306-1308
7. Blatt P., McFarland D., and Eifrig D. Ophthalmic surgery and plasma thromboplastin antecedent (factor XI) deficiency. Arch Ophthalmol 98 (1980) 863-864
8. Iyengar S.S., Olitsky S.E., and Neville K.A. Diagnosis of Factor XI deficiency following congenital cataract extraction. J AAPOS 12 (2008) 297-298
9. Lawler P., White B., Pye S., et al. Successful use of recombinant factor VIIa in a patient with inhibitor secondary to severe factor XI deficiency. Haemophilia 8 (2002) 145-148
10. Leblebisatan G., Sasmaz I., Antmen B., Kilinc Y., Sizmaz S., and Yaqmur M. A successful use of recombinant factor VIIa in a patient with inhibitors, for bilateral cataract operation and circumcision. Haemophilia 12 (2006) 187-189
11. Salomon O., Steinberg D.M., and Seligshon U. Variable bleeding manifestations characterize different types of surgery in patients with severe factor XI deficiency enabling parsimonious use of replacement therapy. Haemophilia 12 (2006) 490-493
12. Barequet I.S., Sachs D., Priel A., et al. Phacoemulsification of cataract in patients receiving coumadin therapy: ocular and hematologic risk assessment. Am J Ophthalmol 144 (2007) 719-723.e1
13. Jamula E., Anderson J., and Douketis J.D. Safety of continuing warfarin therapy during cataract surgery: A systematic review and meta-analysis. Thromb Res 124 (2009) 292-299
14. O'Connell N.M., Riddell A.F., Pascoe G., Perry D.J., and Lee C.A. Recombinant factor VIIa to prevent surgical bleeding in factor XI deficiency. Haemophilia 14 (2008) 775-781
15. Salomon O., Steinberg D.M., Koren-Morag N., Tanne D., and Seligsohn U. Reduced incidence of ischemic stroke in patients with severe factor XI deficiency. Blood 111 (2008) 4113-4117
16. Jabbur N.S. Excessive fibrin after cataract surgery associated with aminocaproic acid use. J Cataract Refract Surg 29 (2003) 1636-1637
17. Loewy D.M., Williams P.B., Crouch Jr. E.R., and Cooke W.J. Systemic aminocaproic acid reduces fibrinolysis in aqueous humor. Arch Ophthalmol 105 (1987) 272-276
18. Salomon O., Steinberg D., Tamarin I., Zivelin A., and Seligsohn U. Plasma replacement therapy during labor is not mandatory for women with severe factor XI deficiency. Blood Coagul Fibrinolysis 16 (2005) 37-41
19. Benzimra J.D., Johnston R.L., Jaycock P., et al. The Cataract National Dataset electronic multicentre audit of 55,567 operations: antiplatelet and anticoagulant medications. Eye 23 (2009) 10-16
20. Schafer A.I. Effects of nonsteroidal anti-inflammatory drugs on platelet function and systemic hemostasis. J Clin Pharmacol 35 (1995) 209-219